Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 18.50 16.00 21.00 18.50 18.50 18.50 291 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.9 -7.8 -31.9 - 6

Genedrive Share Discussion Threads

Showing 51 to 70 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
05/11/2019
08:27
Hardman interview discussing their recent note - http://bit.ly/2NgBTNg
astonedt
28/10/2019
08:53
Hardman research out today - Now was someone front running last week in the hope of a pop - So far no share price reaction - Possibly as although dated today Hardman Reserach gives share price as 16p Still forecast as loss making through both 2020& 2012.
pugugly
23/10/2019
16:16
This flies if mgt executes
the ghost who walks
23/10/2019
09:03
There they go - down again - massive overhang and stale investors possibly taking pop to get out - Will be interesting to see where ends the day - If stop-losses in palace could possibly end up in the red - Anyone know if tipped and if so where?
pugugly
03/10/2019
08:12
Results out - Delays and delays - burning cash - OK some interesting technology but forward vision still (imo very foggy) as to whether the company will ever be commercially successful - Still waiting - Very appropriate - Personally I will be watching and waiting - If ever decide to enter will be at a significanlty lower point (now 15p/18p)
pugugly
14/9/2019
09:34
Looking forward to the results in october
the ghost who walks
02/9/2019
19:24
Quiet here
the ghost who walks
18/7/2019
07:23
Now could this this be a concerted effort to pump the shares? "Dr Ian Gilham, Non-Executive Chairman, acquired 51,250 ordinary shares of 1.5p each ("Ordinary Shares") in the Company at an average price of 19p per share" At a cost of £9,737.50 plus dealing - Not really betting the farm! Next day Edison issue a note - https://www.hardmanandco.com/research/corporate-research/hepatitis-c-market-frustrations/?dm_i=49CL,M60N,VNY52,2LNKT,1 Humm--------------
pugugly
09/7/2019
07:45
Looks as though bad news in trading update was expected - Now 18p bid 20p offered - Could this go down to say 15p bid - Seems very unloved - way below last fundraising at 23p. Market cap now ADVFN £6.5m
pugugly
04/7/2019
11:37
SP Continuing to drift down - Seems most unloved - Still waiting on the side - Possibly easy to buy Impossible to sell -
pugugly
19/12/2018
10:47
Hardman & Co Q&A discussing Genedrive - http://bit.ly/2Bq8060
astonedt
10/12/2018
14:52
Looks like Odey did not take part in the placing and prefered to take a bath - Message sent very clear - imo
pugugly
16/11/2018
09:48
Fundraising announced at 23p plus convertibles but from market reaction looks very much like a non event -
pugugly
10/10/2018
06:57
Anyone still following - Quiet as the grave here -
pugugly
02/10/2018
08:39
Genedrive (GDR) News Out Just Now http://crweworld.com/article/news-provided-by-globenewswire/822013/genedrive-to-release-genedrive-connect-mobile-app
danieldanj
24/8/2018
08:49
Woops!!!!! 656Public companies: duty of directors to call meeting on serious loss of capital (1)Where the net assets of a public company are half or less of its called-up share capital, the directors must call a general meeting of the company to consider whether any, and if so what, steps should be taken to deal with the situation. (2)They must do so not later than 28 days from the earliest day on which that fact is known to a director of the company. (3)The meeting must be convened for a date not later than 56 days from that day. (4)If there is a failure to convene a meeting as required by this section, each of the directors of the company who— (a)knowingly authorises or permits the failure, or (b)after the period during which the meeting should have been convened, knowingly authorises or permits the failure to continue,commits an offence. (5)A person guilty of an offence under this section is liable— (a)on conviction on indictment, to a fine; (b)on summary conviction, to a fine not exceeding the statutory maximum. (6)Nothing in this section authorises the consideration at a meeting convened in pursuance of subsection (1) of any matter that could not have been considered at that meeting apart from this section.
pugugly
02/11/2017
07:18
Sounds possibly fatal to the TB India programme ! https://www.investegate.co.uk/genedrive-plc--gdr-/rns/distribution-update-for-india/201711020700053351V/ Only questions are - * How much of a hit will the share price take today ? * What value is left in the company ?
pugugly
17/10/2017
13:37
Despite the rise in today’s share price, Genedrive’s results are poor. Revenue missed their £7m forecast and net losses widened to £6.4m, greater than their sales of £5.8m. The problems facing this diagnostic business is two-fold: -One R&D expenses account for 90% of group sales (normally you would expect 20%). Also, it grows larger as sales increase. -Two staff costs represent half of sales. Also, 40% of group sales is reliance on grant funding which is a volatile source of income. But, right now it is helping to mask internal sales weakness within the business. Those who participate in last year placing at 80p is down by 55%. For more Genedrive analysis and other analysis on companies’ results, click http://bit.ly/2hLViFb
walbrock82
16/10/2017
10:41
Bought in today for results pretty much MC in bank surely can't go wrong
johns288
05/7/2017
10:14
See previous
the ghost who walks
Chat Pages: 3  2  1
Your Recent History
LSE
GDR
Genedrive
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191115 00:14:35